CDH1 and cancer: EMT is characterized by the downregulation of epithelial markers, such as E-cadherin, and the upregulation of mesenchymal features, which facilitate enhanced motility and invasiveness in cancer cells (Drasin et al., 2011; Wang and Zhou, 2011).